Curaleaf Holdings (CURLF) Other Working Capital Changes (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Other Working Capital Changes of -$7.1 million for Q4 2024, down 705.91% year-on-year from $1.2 million in Q1 2024, and down 166.42% on a QoQ basis from -$2.7 million in Q3 2024.
Curaleaf Holdings (CURLF) Other Working Capital Changes (2019 - 2024) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Other Working Capital Changes for 6 consecutive years, with -$7.1 million the latest figure, recorded in Q4 2024.
- Quarterly Other Working Capital Changes fell 705.91% year-over-year to -$7.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$12.1 million (down 6.23% YoY) and the FY2025 annual result came in at -$17.9 million, down 9.27% from the prior year.
- Other Working Capital Changes declined to -$7.1 million in Q4 2024 per CURLF's latest filing, from -$2.7 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for CURLF reached as high as $13.8 million in Q4 2023 and fell as low as -$15.9 million in Q1 2021.
- A 5-year average of -$649875.0 and a median of $566500.0 in 2020 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2020 — Other Working Capital Changes sank 1682.44% — and 2021, when it soared 1958.42%.
- Year by year, Other Working Capital Changes stood at -$23.2 million in 2020, then surged by 109.67% to $2.2 million in 2021, then soared by 1189.5% to $29.0 million in 2022, then plunged by 103.04% to -$880000.0 in 2023, then plunged by 705.91% to -$7.1 million in 2024.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$7.1 million, -$2.7 million, and -$880000.0 for Q4 2024, Q3 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.09 Mn |
| Dec 31, 2024 | -2.09 Mn |
| Dec 31, 2024 | -2.09 Mn |
| Sep 30, 2024 | 1.77 Mn |
| Sep 30, 2024 | 1.77 Mn |
| Sep 30, 2024 | 1.77 Mn |
| Dec 31, 2023 | 13.79 Mn |
| Dec 31, 2023 | 13.79 Mn |
| Dec 31, 2023 | 13.79 Mn |
| Sep 30, 2023 | 549,000.00 |
| Sep 30, 2023 | 549,000.00 |
| Sep 30, 2023 | 549,000.00 |
| Dec 31, 2022 | -2.23 Mn |
| Dec 31, 2022 | -2.23 Mn |
| Dec 31, 2022 | -2.23 Mn |
| Sep 30, 2022 | 3.36 Mn |
| Sep 30, 2022 | 3.36 Mn |
| Sep 30, 2022 | 3.36 Mn |
| Jun 30, 2022 | 3.71 Mn |
| Jun 30, 2022 | 3.71 Mn |